NEWSLETTER
A fresh look, and deeper analysis
End-to-end, in two phases
Invalidity · Infringement · FTO · Novelty
We’ve made Stilta’s two-phase flow explicit — it’s how customers have extracted the most value. First, guided setup kicks off an autonomous run (10–20 minutes of search and analysis). From there, you step in as the director — filling gaps and tailoring the analysis, with agents on hand, across every deep-analysis module.
A refreshed user interface
Across the platform
We’ve rebuilt the look and feel of the platform: a unified color palette, a cleaner layout with fewer tabs, and clearer visuals throughout. Everything is easier to scan and faster to move through.
Configurable claim interpretations
Invalidity · Infringement
Claim charts now run broad, narrow, and proposed readings, so you can see exactly how interpretation changes the claim-to-evidence match. Fully editable — you stay in the loop and can override any reading, as always.
Stronger search capabilities
Invalidity · Infringement · FTO · Novelty
Search now finds 5–10× more evidence in the first phase and produces an initial mapping for you, drawing on more data sources than before (PubChem, FDA records, and more). Every chart stays 100% source-backed — now with even more references behind it.
…and more across the modules
Third-Party Observations (TPO) for invalidity, custom company and target-research reports in infringement, new Reexam, IPR and PGR report paths, Excel/CSV patent-list import in guided setup, automatic prosecution-history retrieval for non-US targets, PDF highlighting on image-only documents, and new standard-essential patent (SEP) analysis — declared SEPs mapped against 3GPP and ETSI specifications.
Want a walkthrough of what’s new?
Book a chat →
Or just reach out — we read every message, and there’s no better input than yours.